- Home
- OLN vs VKTX Comparison
OLN vs VKTX Comparison
Compare OLN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLN | VKTX |
|---|---|---|
| Founded | 1892 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OLN | VKTX |
|---|---|---|
| Price | $23.89 | $32.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | $23.07 | ★ $88.00 |
| AVG Volume (30 Days) | ★ 3.4M | 3.0M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,780,800,000.00 | N/A |
| Revenue This Year | $1.55 | N/A |
| Revenue Next Year | $3.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.68 | N/A |
| 52 Week Low | $17.66 | $18.92 |
| 52 Week High | $27.35 | $43.15 |
Technical Indicators
Market Signals| Indicator | OLN | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 55.07 |
| Support Level | $19.16 | $30.73 |
| Resistance Level | $24.48 | $35.64 |
| Average True Range (ATR) | 1.29 | 1.85 |
| MACD | -0.20 | 0.63 |
| Stochastic Oscillator | 13.72 | 66.55 |
Price Performance
Historical ComparisonAbout OLN Olin Corporation
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.